InvestorsHub Logo
Followers 4
Posts 112
Boards Moderated 0
Alias Born 03/02/2024

Re: badgerkid post# 871

Sunday, 05/19/2024 12:27:20 PM

Sunday, May 19, 2024 12:27:20 PM

Post# of 1834
Great find Badger. This video nicely summarizes what most of us have been saying all along. My biggest concern is why is SP tanking in a free fall and why are the big boys are not placing some breaks. I’ve seen this free fall with many biotech stocks I’ve owned before which eventually spiked and believe it is done to transfer shares from small guys to big guys and make money on puts prior to releasing big news. Overall Response of over 60% in 10 patients data is not enough to impress FDA to do away with requirement for Phase 3.
To be impressive. I hope they are announcing data in at least 30 patients (50 even better) at ASCO to prove initial data (60% OR) seen in first 10 patients reproduces similar results in subsequent cohorts of 10 patients over and over again. This will set the SP back on the right trajectory as concerns about high expenses and low revenue will abate. All that will
Matter is demand is going to be blockbuster and big pharma is more likely to take over sooner. Risk of dilution may still exist in later part of 3rd Qtr or early 4th Qtr to improve negotiations with the big pharma buyer. Bottom line, I sure hope SP goes back up early next week and jumps up on announcement of outstanding news. My best wishes to all of us who own IOVA shares and believe in TIL technology and its place in cancer treatment in the decades to follow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News